|
Industry: Pharma
|
|
|
| A Guidebook of Registration Application for Imported Biological Products provides a comprehensive and thorough knowledge of application for imported biological product registration with the Chinese drug regulatory authorities to guide overseas... |
|
|
| Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes
Summary
GBI Research’s new report, “Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion |
|
|
| Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities
Summary
GBI Research, the leading business intelligence provider, has released its latest research “Cell Culture |
|
|
| Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen
Summary
GBI Research, a leading business intelligence provider, has released its latest research, “Contraceptives Marke |
|
|
| Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
Summary
GBI Research, a leading business intelligence provider, has released |
|
|
| HIV/AIDS Therapeutics Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth
Summary
GBI Research, a leading business intelligence provider, has released its latest research, “HIV |
|
|
| Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth
Summary
GBI Research, the leading business intelligence provider, |
|
|
| Women’s Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy
Summary
GBI Research, a leading business intelligence provider, has releas |
|
|
| 1300 Smiles Limited (ONT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
1300 Smiles Limited (Smiles) is a dental service company, provides dentistry services in Australia to private dentists. The company provides facilities s |
|
|
| 22nd Century Group, Inc. (XXII) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
22nd Century Group, Inc. is a metals and mining company. The company is engaged in acquisition, exploration and development of mineral resource pro |
|